Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ФГБУ Научный центр психического здоровья Российской академии медицинских наук, Москва; 2НОКЦ Психосоматическая медицина ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России; 3Факультет послевузовского профессионального образования врачей ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России
Список исп. литературыСкрыть список 1. Вазагаева Т.И. Качество и стойкость ремиссии при применении антидепрессантов и трансперсональной психотерапии у больных с депрессивными расстройствами. Автореф. дис. … канд. мед. наук. М., 2010. 2. Городничев А.В., Костюкова Е.Г., Мосолов С.Н. Достижение ремиссии как основная цель длительной терапии рекуррентного депрессивного расстройства (анализ данных литературы и результатов оригинального сравнительного рандомизированного исследования антидепрессантов разных поколений). Соврем. терапия психических расстройств. 2009; 1: 5–10. 3. Захарова К.В. Качество и стойкость ремиссии при применении фармакотерапии у больных с депрессивными расстройствами. Автореф. дис. … канд. мед. наук. 2008. 4. Смулевич А.Б., Андрющенко А.В., Романов Д.В., Захарова Н.В. Ремиссии при аффективных заболеваниях (эпидемиология, психопатология, клинический и социальный прогноз, вторичная профилактика). Журн. неврологии и психиатрии им. С.С.Корсакова. 2014; 114 (3): 4–13. 5. Смулевич А.Б. Расстройства личности. Траектория в пространстве психической патологии. М., 2012. 6. Суханов С.А. Циклотимия и психастения и их отношение к неврастении. Русский врач. 1903; 3: 79–81. 7. Циркин С.Ю. Концептуальная диагностика функциональных расстройств: диатез и шизофрения. Соц. и клин. психиатрия. 1995; 2: 114–8. 8. Читлова В.В. Тревожная депрессия и расстройства личности (коморбидность, типологическая дифференциация, терапия). Автореф. дис. … канд. мед. наук. М., 2013. 9. Шостакович Б.В. О классификации психопатий. Журн. невропат. и психиатрии им. С.С.Корсакова. 1988; 88 (11): 1675–84. 10. Шостакович Б.В. Расстройства личности (психопатии) в судебно-психиатрической практике. М., 2006. 11. Abramson LY, Sackeim HA. A paradox in depression: Uncontrollability and selfblame. Psychol Bull 1977; 84: 838–51. 12. Akiskal HS. Personality as a mediating variable in the pathogenesis of mood disorders: Implications for theory, research and prevention. Depressive illness: Prediction of course and outcome 1988; p. 113–46. 13. Akiskal HS, Akiskal K. Cyclothymic, hyperthymic and depressive temperaments as subaffective variants of mood disorders. Ann Rev Psychiatr 1992; 11: 43–62. 14. Alnaes R, Torgersen S. Personality and personality disorders predict development and relapses of major depression. Acta Psychiatr Scand 1997; 95 (4): 336–42. 15. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder 2000. 16. Anderson IM, Nutt DJ, Deakin JFW. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol 2000; 14: 3–20. 17. Angst J. The history and concept of recurrent brief depression. Eur Arch Psychiatry Clin Neurosci 1994; 244: 171–3. 18. Australian and New Zealand clinical practice guidelines for the treatment of depression, 2004. 19. Ayuso-Mateos JL, Nuevo R, Verdes E et al. From depressive symptoms to depressive disorders: the relevance of thresholds. Br J Psychiatry 2010; 196 (5): 365–71. 20. Bauer M, Whybrow PC, Angst J et al. World Federation of Societies of Biological Psychiatry (WFSBF) Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry 2002; 3 (2): 69–86. 21. Berlanga C et al. Personality and Clinical Predictors of Recurrence of Depression. Psychiatr Serv 1999; 50: 376–80. 22. Bockting CL, Lok A, Visser I et al; DELTA study group. Lower cortisol levels predict recurrence in remitted patients with recurrent depression: a 5.5/- year prospective study. Psychiatry Res 2012; 200 (2–3): 281–7. 23. Broadaty H et al. 25-year longitudinal, comparison study of the outcome of depression. Psychol Med 2001; 31: 1347–59. 24. Canadian Psychiatric Association and Canadian Network for Mood and Anxiety Treatments. Clinical guidelines for the treatment of depressive, 2001. 25. Clayton PJ, Marten S, Davis MA, Wochnik E. Mood disorder in women professionals. J Affect Disord 1980; 2: 37–46. 26. Clinical Practice Guideline Number 5: Depression in Primary Care, 1993. 27. Colman I, Naicker K, Zeng Y et al. Predictors of long-term prognosis of depression. CMAJ 2011; 183: 1969–76. 28. Cyranowski JM et al. Personality pathology and outcome in recurrently depressed women over 2 years of maintenance interpersonal psychotherapy. Psychol Med 2004; 34 (4): 659–69. 29. Dombrovski AY, Frank E et al. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy? Depress Anxiety 2008; 25 (12): 1060–6. 30. Dombrovski AY et al. Residual symptoms and recurrence during maintenance treatment of late-life depression J Affect Disord 2007; 103 (1–3): 77–82. 31. Dupuy JM, Ostacher MJ, Huffman J et al. A critical review of pharmacotherapy for major depressive disorder. Int J Neuropsychopharmacol 2011; 14 (10): 1417–31. 32. Eaton WW, Shao H, Nestadt G et al. Population-Based Study of First Onset and Chronicity in Major Depressive Disorder. Arch Gen Psychiatry 2008; 65 (5): 513–20. 33. Ezquiaga E, Garcia A, Bravo F, Pallares T. Factors associated with outcome in major depression: a 6-month prospective study. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 552–7. 34. Faravelli C, Ambonetti A, Pallanti S, Pazzagli A. Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 1986; 143: 888–91. 35. Fava GA, Ruini Ch, Belaise C et al. The concept of recovery in major depression Psychol Med 2007; 37 (3): 307–17. 36. Fava GA Grandi S, Zielezny M et al. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994; 151: 1295–9. 37. Fava M, Alpert J, Borus J et al. Patterns of personality disorder comorbidity in depression. Psychosomatics 1996; 37: 31–7. 38. Ferguson E, Matthews G, Cox T. The appraisal of life events (ALE) scale: reliability, and validity. Br J Health Psychol 1999; 4: 97–116. 39. Frank E et al. Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder. Remission, Recovery, Relapse, and Recurrence. Arch Gen Psychiatry 1991; 48: 851–5. 40. Gastó C, Navarro V, Catalán R et al. Residual symptoms in elderly major depression remitters. Acta Psychiatr Scand 2003; 108: 15–9. 41. Golin S, Sweeney PD, Shaeffer DE. The causality of causal attributions in depression: A cross-lagged panel correlational analysis. J Abnorm Psychol 1981; 90: 14–22. 42. Gorwood P, Rouillon F, Even C et al. Treatment response in major depression: effects of personality dysfunction and prior depression. Br J Psychiatry 2010; 196 (2): 139–42. 43. Greenberg MA, Wortman CB, Stone AA. Emotional expression and physical heath. Revising traumatic memories or fostering self-regulation? J Pers Soc Psychol1996; 71: 588. 44. Grilo CM et al. Two-Year Prospective Naturalistic Study of Remission From Major Depressive Disorder as a Function of Personality Disorder Comorbidity. J Consult Clin Psychol 2005; 73 (1): 78–85. 45. Gureje O, Maj M et al. Образовательная программа по депрессивным расстройствам, ВОЗ (редакция 2008 г.). Пер. под ред. В.Н.Краснова. М., 2010. 46. Hart AB et al. Predicting Recurrence of Major Depressive Disorder in Young Adults: A Prospective Study. J Abnorm Psychol 2001; 110 (4): 633–43. 47. Helmchen H, Linden M. Subthreshold disorders in psychiatry: clinical reality, methodological artifact, and the double-threshold problem. Compr Psychiatry 2000; 41: 1–7. 48. Hung Ch-I et al. Residual Symptoms Related to Physical and Panic Symptoms at Baseline Predict Remission of Depression at Follow-Up Psychopathology. 49. Ilardi SS, Craighead WE, Evans DD. Modeling Relapse in Unipolar Depression: The Effects of Dysfunctional Cognitions and Personality Disorders. J Consult Clin Psychol 1997; 65 (3): 381–91. 50. Israel J. The Impact of Residual Symptoms in Major Depression. Pharmaceuticals 2010; 3: 2426–40. 51. Israel JA. Remission in depression: definition and initial treatment approaches. J Psychopharmacol 2006; 20: 5–10. 52. Iwaki Sh et al. Treatment-resistant residual insomnia in patients with recurrent major depressive episodes. Sleep and Biological Rhythms 2012; 10: 202–11. 53. Judd LL et al. A Prospective 12-Year Study of Subsyndromal and Syndromal Depressive Symptoms in Unipolar Major Depressive Disorders. Arch Gen Psychiatry 1998; 55 (8): 694–700. 54. Judd LL, Paulus MJ, Schettler PJ et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000; 157 (9): 1501–4. 55. Kanai T, Takeshi H et al. Time to recurrence after recovery from major depressive episodes and its predictors. Psychol Med 2003; 33 (5): 839–45. 56. Karam EG, SaLamoun MM, Yeretzian JS et al 2010. The role of anxious and hyperthymic temperamtnts in mental disorders: a national epidemiologic study. World Psychyiatry 2010; 9 (2): 103–10. 57. Karp JF, Buysse DJ, Houck PR et al. Relationship of Variability in Residual Symptoms with Recurrence of Major Depressive Disorder During Maintenance Treatment. Am J Psychiatry 2004; 161: 1877–84. 58. Kendler KS, Pedersen NL, Johnson L et al. A pilot Swedish twin study of affective illness, including hospitaland population-ascertained subsamples. Arch Gen Psychiatry 1993; 50: 699–70. 59. Kennedy N, Abbot R, Paykel ES. Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study. Br J Psychiatry 2004; 184: 330–6. 60. Kennedy S. Full remission: a return to normal functioning J Psychiatry Neurosci 2002; 27 (4): 233–34. 61. Kraepelin E. Manic-depressive insanity and paranoia. Edinburg, 1921; p. 149–50. 62. Kraines SH. Therapy of the chronic depressions. Dis Nerv Syst 1967; 28 (9): 577–84. 63. Kupfer DJ, Frank E, Perel JM et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992; 49: 769–73. 64. Ladee GA. Hypochondrische Syndromes. Amsterdam, London, NY, 1966. 65. Lavori PW, Keller MB et al. Reccurence after recovery in unipolar major depressive disorder: An observational follow-up study of clinical predictors and somatic treatment as a mediating factor. Int J Methods Psychol Res 1994; p. 211–29. 66. Lemke R. Über die Bedeutung der Leibgefühle in der psychiatrischen Diagnostik. Psychiatr Neurol Med Psychol (Lpz) 1951; 3: 325–40. 67. Maier W, Lichtermann D, Oehrlein A, Fickinger M. Depression in the community: A comparison of treated and non-treated cases in two non-referred samples. Psychopharmacology 1992; 106: 79–81. 68. Maj M, Veltro F, Pirozzi S et al. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992; 149: 795–800. 69. Mattisson C, Bogren M, Horstmann V et al. The long-term course of depressive disorders in the Lundby Study. Psychol Med 2007; 37 (6): 883–91. 70. Montgomery SA, Montgomery D, Baldwin D, Green M. The duration, nature and recurrence rate of brief depressions. Prog Neuro Psychopharmacol Biol Psychiatry 1990; 14: 729–35. 71. Mueller TI, Leon AC, Keller MB et al. Recurrence After Recovery From Major Depressive Disorder During 15 Years of Observational Follow-Up. Am J Psychiatry 1999; 156: 1000–6. 72. Mueller TI, Keller MB, Leon AC et al. Recovery after 5 years of unremitting major depressive disorder. Arch Gen Psychiatry 1996; 53: 794–9. 73. Nierenberg AA, Keefe BR, Leslie VC et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999; 60: 221–5. 74. Nutt DJ, Davidson JR, Gelenberg AJ et al. International consensus statement on major depressive disorder. J Clin Psychiatry 2010; 71 (Suppl. E1): e08. 75. Opdyke KS, Reynolds CF, Frank E et al. Effect of continuation treatment on residual symptoms in late-life depression: how well is “well”? Depress Anxiety 1996/97; 4: 312–9. 76. Ormel J, Oldehinkel A, Vollebergh W. Vulnerability before, during and after a major depressive episode. Arch Gen Psychiatry 2004; 61: 990–6. 77. Paskind HA. Brief Attacks of Manic-Depressive Depression. Arch Neur Psychiatry 1929; 22 (1): 123–34. 78. Patkar AA, Pae CU. Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder. CNS Drugs 2013; 27 (Suppl. 1): S29–37. 79. Paykel ES, Scott J, Teasdale JD et al. Prevention of relapse in residual depression by cognitive therapy. Arch Gen Psychiatry 1999; 56: 829–35. 80. Perugi G, Fornano M, Akiskal HS. Are atypical depression, borderline personality disorder and bipolar ІІ disorder overlapping manifestations of common cyclothymic diathesis? World Psychiatry 2011; 10: 45–51. 81. Pettit JW et al. Is Liability to Recurrent Major Depressive Disorder Present Before First Episode Onset in Adolescence or Acquired After the Initial Episode? J Abnorm Psychol 2013; 122 (2): 353–8. 82. Pilowsky I. Abnormal illness behavior (dysnosognosia). Psychother Psychosom 1986; 46: 248–56. 83. Rado S. Dynamics and classification of disturbances of behavior. Am J Psychiatry 1953; 6. 84. Ramana R, Paykel ES, Cooper Z et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995; 25: 1171–80. 85. Romera I et al. Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis. BMC Psychiatry 2013; 13: 51. 86. Rush AJ, Trivedi MH, Wisniewski SR et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905. 87. Sanderson W, Beck A, Keswani L. Prevalence of personality disorders in patients with major depression and dysthymia. Psychiatry Res 1992; 42: 92–9. 88. Segal ZV. Antidepressant Monotherapy versus Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression. Arch Gen Psychiatry 2010; 67 (12): 1256–64. 89. Shimoda M. Über das manisch-depressive Irresein. Med Zischr Yonago 1950; 2: 1–2. 90. Simon GE. Long-term prognosis of depression in primary care. Bull World Health Organ 2000; 78: 439–45. 91. Solomon DA, Keller MB, Leon AC et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000; 157: 229–33. 92. Spijker JAN, de Graaf RON, Bijl RV et al. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 2002; 181 (3): 208–13. 93. Steunenberg B, Beekman ATF, Deeg DJH, Kerkhof JFM. Personality predicts recurrence of late-life depression. J Affect Disord 2010; 123: 164–72. 94. Surtees PG, Barkley C. Future imperfect: the long-term outcome of depression. Br J Psychiatry 1994; 164: 327–41. 95. Tellenbach H. Melancholy: History of the problem. Endogenerity, typology, pathogenesis, clinical considerations. Pittsburgh, PA: Duquesne University Press, 1961. 96. ten Doesschate MC, Bockting CL, Koeter MW, Schene AN. DELTA Study. Prediction of recurrence in recurrent depression: a 5,5-year prospective study. J Clin Psychiatry 2010; 71 (8): 984–91. 97. Thase ME. Achieving Remission and Managing Relapse in Depression. J Clin Psychiatry 2003; 64 (Suppl. 18): 3–7. 98. Thornicroft G, Sartorius N. The course and outcome of depression in different cultures: 10-year follow-up of the WHO Collaborative Study on the Assessment of Depressive Disorders. Psychol Med 1993; 23: 1023–32. 99. Verbeek E. La psychopatie. Psychiat Neurol Basel 1960; 3 (139): 140–78. 100. von Leuter H. Phasenuberdauern der Persönlichkeitswandel und persistierende Symptome bei der endogenen Depression. In: Das Depressive Syndrome. Uerban & Schwаrzenberg, 1968; s. 127–52. 101. Vuorilehto MS, Melartin TK, Isometsä ET. Course and outcome of depressive disorders in primary care: a prospective 18-month study. Psychol Med 2009; 39: 1697–707. 102. Weissman MM, Prusoff BA, Klerman GL. Personality and the Prediction of Long-Term Outcome of Depression. Am J Psychiatry 1978; 135 (7): 797–800. 103. Weitbrecht HJ. Zur Typologie depressiver Psychosen. Forschr Neurol Psychiatr 1952; 20: 247. 104. Whitmer G. On the nature of dissociation. Psychoanal Q 2001; 70 (4): 807–37. 105. Zajecka J. Treating Depression to Remission J Clin Psychiatry 2003; 64 (Suppl. 15): 7–12. 106. Zimmerman M et al. How should residual symptoms be defined in depressed patients who have remitted? Compr Psychiatry 2013; 54: 91–6. 107. Zuckerman DM, Prusoff BA, Weissman MM, Padian NS. Personality as a predictor of psychotherapy and pharmacotherapy outcome for depressed outpatients. J Consult Clin Psychol 1980; 48 (6): 730–5.